Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.3390/IJMS19040956 | ||||
| Año | 2018 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Progressive neurodegenerative pathologies in aged populations are an issue of major concern worldwide. The microtubule-associated protein tau is able to self-aggregate to form abnormal supramolecular structures that include small oligomers up to complex polymers. Tauopathies correspond to a group of diseases that share tau pathology as a common etiological agent. Since microglial cells play a preponderant role in innate immunity and are the main source of proinflammatory factors in the central nervous system (CNS), the alterations in the cross-talks between microglia and neuronal cells are the main focus of studies concerning the origins of tauopathies. According to evidence from a series of studies, these changes generate a feedback mechanism reactivating microglia and provoking constant cellular damage. Thus, the previously summarized mechanisms could explain the onset and progression of different tauopathies and their functional/behavioral effects, opening the window towards an understanding of the molecular basis of anomalous tau interactions. Despite clinical and pathological differences, increasing experimental evidence indicates an overlap between tauopathies and synucleinopathies, considering that neuroinflammatory events are involved and the existence of protein misfolding. Neurofibrillary tangles of pathological tau (NFT) and Lewy bodies appear to coexist in certain brain areas. Thus, the co-occurrence of synucleinopathies with tauopathies is evidenced by several investigations, in which NFT were found in the substantia nigra of patients with Parkinson's disease, suggesting that the pathologies share some common features at the level of neuroinflammatory events.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Cortes, Nicole | Mujer |
Centro Internacional de Biomedicina - Chile
International Center for Biomedicine (ICC) - Chile Int Ctr Biomed ICC - Chile |
| 2 | Andrade, Victor | Hombre |
Centro Internacional de Biomedicina - Chile
International Center for Biomedicine (ICC) - Chile Int Ctr Biomed ICC - Chile |
| 3 | Guzman-Martinez, Leonardo | Hombre |
Centro Internacional de Biomedicina - Chile
International Center for Biomedicine (ICC) - Chile Int Ctr Biomed ICC - Chile |
| 4 | Estrella, Matias | Hombre |
Centro Internacional de Biomedicina - Chile
International Center for Biomedicine (ICC) - Chile Int Ctr Biomed ICC - Chile |
| 5 | MACCIONI-BARAHONA, RICARDO BENJAMIN | Hombre |
Centro Internacional de Biomedicina - Chile
Universidad de Chile - Chile International Center for Biomedicine (ICC) - Chile Int Ctr Biomed ICC - Chile |
| Agradecimiento |
|---|
| Research was supported by INNOVA Corfo grants on High Technology and Technological Innovation and to the International Center for Biomedicine (ICC). We would like to acknowledge these institutions for their generous financial support to carry out this research. We also would like to acknowledge Constanza Maccioni y Jose Pablo Tapia for their help in this research process, and to Nicolas Ramos for his suggestions in the article revision. |
| Acknowledgments: Research was supported by INNOVA Corfo grants on High Technology and Technological Innovation and to the International Center for Biomedicine (ICC). We would like to acknowledge these institutions for their generous financial support to carry out this research. We also would like to acknowledge Constanza Maccioni y José Pablo Tapia for their help in this research process, and to Nicolas Ramos for his suggestions in the article revision. |